Digital Breast Tomosynthesis as a Breast Cancer Screening Tool for Women with Gynecologic Cancer

다국어 초록 (Multilingual Abstract)

Purpose The purpose of our study was to evaluate digital breast tomosynthesis as a breast cancer screening modality for women with gynecologic cancer.
Materials and Methods This retrospective study included patients with underlying gynecologic malignancies who underwent screening digital breast tomosynthesis for breast cancer. The cancer detection rate, recall rate, sensitivity, specificity, and positive predictive value (PPV) were calculated.
PPV1 was defined as the percentage of all positive screening exams that have a tissue diagnosis of cancer within a year. PPV2 was defined as the percentage of all diagnostic exams (and Breast Imaging Reporting and Data System category 4, 5 from screening setting) with a recommendation for tissue diagnosis that have cancer within a year. PPV3 was defined as the percentage of all known biopsies actually performed that resulted in a tissue diagnosis of cancer within the year. For each case of screen-detected cancer, we analyzed the age, type of underlying gynecologic malignancy, breast density, imaging features, final Breast Imaging Reporting and Data System assessment, histologic type, T and N stages, molecular subtype, and Ki-67 index.
Results Among 508 patients, 7 with breast cancer were identified after a positive result. The cancer detection rate was 13.8 per 1000 screening exams, and the recall rate was 17.9%. The sensitivity was 100%, and the specificity was 83.2%. The false negative rate was 0 per 1000 exams.
The PPV1, PPV2, and PPV3 were 7.7, 31.8, and 31.8, respectively.
Conclusion Digital breast tomosynthesis may be a promising breast cancer screening modality for women with gynecologic cancer, based on the high cancer detection rate, high sensitivity, high PPV, and high detection rate of early-stage cancer observed in our study.

참고문헌 (Reference)

1 Komenaka IK, "The development of interval breast malignancies in patients with BRCA mutations" 100 : 2079-2083, 2004

2 Tabár L, "Swedish two-county trial : impact of mammographic screening on breast cancer mortality during 3 decades" 260 : 658-663, 2011

3 Warner E, "Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination" 292 : 1317-1325, 2004

4 Lehman CD, "Screening women at high risk for breast cancer with mammography and magnetic resonance imaging" 103 : 1898-1905, 2005

5 Leach MO, "Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer : a prospective multicentre cohort study(MARIBS)" 365 : 1769-1778, 2005

6 US Preventive Services Task Force, "Screening for breast cancer : U. S. Preventive Services Task Force recommendation statement" 151 : 716-726, 2009

7 Win AK, "Risk of breast cancer in Lynch syndrome : a systematic review" 15 : R27-, 2013

8 Brekelmans CT, "Risk factors and risk reduction of breast and ovarian cancer" 15 : 63-68, 2003

9 Welch HG, "Quantifying the benefits and harms of screening mammography" 174 : 448-454, 2014

10 Allred DC, "Prognostic and predictive factors in breast cancer by immunohistochemical analysis" 11 : 155-168, 1998

11 Hlawatsch A, "Preoperative assessment of breast cancer : sonography versus MR imaging" 179 : 1493-1501, 2002

12 Henderson LM, "Performance of digital screening mammography among older women in the United States" 121 : 1379-1386, 2015

13 NCI-funded Brest Cancer Surveillance Consortium, "Performance Benchmarks for Screening Mammography"

14 Sardanelli F, "Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging(the high breast cancer risk italian 1 study) : final results" 46 : 94-105, 2011

15 Kuhl CK, "Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer" 23 : 8469-8476, 2005

16 Cheang MC, "Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer" 101 : 736-750, 2009

17 Ciatto S, "Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening(STORM) : a prospective comparison study" 14 : 583-589, 2013

18 Carney PA, "Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography" 138 : 168-175, 2003

19 Sharpe RE Jr, "Increased cancer detection rate and variations in the recall rate resulting from implementation of 3D digital breast tomosynthesis into a population-based screening program" 278 : 698-706, 2016

20 Park IH, "High volumetric breast density predicts risk for breast cancer in postmenopausal, but not premenopausal, Korean Women" 21 : 4124-4132, 2014

21 Kriege M, "Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition" 351 : 427-437, 2004

22 McDonald ES, "Effectiveness of digital breast tomosynthesis compared with digital mammography : outcomes analysis from 3 years of breast cancer screening" 2 : 737-743, 2016

23 Hofvind S, "Digital breast tomosynthesis and synthetic 2D mammography versus digital mammography : evaluation in a population-based screening program" 287 : 787-794, 2018

24 Ring KL, "Current and future role of genetic screening in gynecologic malignancies" 217 : 512-521, 2017

25 Haas BM, "Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening" 269 : 694-700, 2013

26 Skaane P, "Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program" 267 : 47-56, 2013

27 Desmond A, "Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment" 1 : 943-951, 2015

28 Monticciolo DL, "Breast cancer screening in women at higher-than-average risk : recommendations from the ACR" 15 : 408-414, 2018

29 Kuhl CK, "Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene : preliminary results" 215 : 267-279, 2000

30 McDonald ES, "Baseline screening mammography : performance of full-field digital mammography versus digital breast tomosynthesis" 205 : 1143-1148, 2015

31 Rafferty EA, "Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone : results of a multicenter, multireader trial" 266 : 104-113, 2013

32 Kim SH, "Analysis and comparison of breast density according to age on mammogram between Korean and western women" 42 : 1009-1014, 2000

33 Saslow D, "American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography" 57 : 75-89, 2007

34 Mariscotti G, "Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer" 34 : 1219-1225, 2014

35 Sickles EA, "ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System" American College of Radiology 2013